Stability of the peritoneal membrane in long-term peritoneal dialysis patients

Advances in Renal Replacement Therapy

Volumn 5, Issue 3, 1998, Pages 168-178

  Selgas, R ^a   Bajo, M A ^a   Paiva, A ^a   Del Peso, G ^a   Diaz, C ^a   Aguilera, A ^a   Hevia, C ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Long term peritoneal dialysis; Peritoneal function; Sclerosing peritonitis

Indexed keywords

CREATININE; UREA;

DIALYSIS MEMBRANE; FIBROSIS; MATERIALS TESTING; PATHOGENESIS; PERITONEAL DIALYSIS; PERMEABILITY; PRIORITY JOURNAL; REVIEW; SCLEROSING PERITONITIS; TREATMENT OUTCOME; ULTRAFILTRATION;

EID: 0031878749     PISSN: 10734449     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1073-4449(98)70029-9     Document Type: Article

References (58)

1. B Rippe R Krediet Peritoneal physiology-transport of solutes R Gokal KD Nolph The Textbook of Peritoneal Dialysis 1994 Kluwer Boston, MA 69 113
2. DG Struijk R Krediet GCM Koomen A prospective study of peritoneal transport in CAPD patients Kidney Int 45 1994 1739 1744
3. B Faller N Lameire Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years Nephrol Dial Transplant 9 1994 280286
4. R Selgas MJ Fernandez-Reyes E Bosque Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study Am J Kidney Dis 23 1994 64 73
5. J Dobbie Ultrastructure and pathology of the peritoneum in peritoneal dialysis R Gokal KD Nolph The Textbook of Peritoneal Dialysis 1994 Kluwer Boston, MA 17 44
6. A Slingeneyer B Canaud C Mion Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: An epidemiological study Nephron 33 1983 133 138
7. VC Gandhi HM Humayun TS Ing Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients Arch Intern Med 140 1980 1201 1203
8. W Drukker Sclerosing peritonitis Dial Transplant 13 1984 A768-G768
9. E Huarte-Loza R Selgas A Rodriguez-Carmona Peritoneal membrane failure as a determinant of the CAPD future Contrib Nephol 57 1987 219 229
10. A Slingeneyer C Mion G Mourad Progressive sclerosing peritonitis: A late and severe complication of maintenance peritoneal dialysis Trans Am Soc Artif Int Org 29 1983 633 638
11. A Slingeneyer Preliminary report on a cooperative international study on sclerosing encapsulating peritonitis Contrib Nephrol 57 1987 239 247
12. J Rottembourg GM Gahl JL Poignet Severe abdominal complications in patients undergoing continuous ambulatory peritoneal dialysis Proc EDTA 20 1983 236 242
13. JW Dobbie JK Lloyd CA Gall Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients R Khanna Advances in Peritoneal Dialysis vol 6 1990 Peritoneal Dialysis Bulletin Toronto, Canada 3 12
14. W Pyle JW Moncrief RP Popovich Peritoneal transport evaluation in CAPD J Moncrief RP Popovich CAPD Update 1981 Masson New York, NY 35 52
15. A Rodriguez-Carmona R Selgas ME Martinez Characteristics of the peritoneal mass transfer of parathormone in patients under continuous ambulatory peritoneal dialysis therapy Nephron 37 1984 21 24
16. R Selgas MA Bajo G Del Peso Preserving the peritoneal dialysis membrane in long-term peritoneal dialysis patients Semin Dial 8 1995 326 332
17. F De Alvaro MJ Castro F Dapena Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failure Adv Perit Dial 9 1993 56 61
18. O Heimburger J Waniewski A Werynski Peritoneal transport characteristics in CAPD patients with permanent loss of ultrafiltration Kidney Int 38 1990 495 506
19. M Pannekeet JK Hiralall DG Struikj Markers of peritoneal mesothelial cells during treatment with peritoneal dialysis Adv Perit Dial 13 1997 17 22
20. Ch-Y Lin W -P Chen L-W Fu Persistent transforming growth factor β-1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence Adv Perit Dial 13 1997 64 71
21. J Dobbie Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis Perit Dial Int 12 1991 14 27
22. S Campbell P Clarke C Hawley Sclerosing peritonitis: Identification of diagnostic, clinical and radiological features Am J Kidney Dis 24 1994 819 825
23. BJR Junor MA MacMillan Immunosuppression in sclerosing peritonitis Adv Perit Dial 9 1993 187 189
24. S Bhandari A Wilkinson I Sellars Sclerosing peritonitis: Value of immunosuppression prior to surgery Nephrol Dial Transplant 9 1994 436 437
25. Y Mori S Matsuo S Sutoh A case of a dialysis patient with sclerosing peritonitis successfully treated with corticosteroid therapy alone Am J Kidney Dis 30 1997 275 278
26. Y Nomoto Y Kawaguchi H Kubo Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: A report of the japanese Sclerosing Encapsulating Peritonitis Study Group Am J Kidney Dis 28 1996 420 427
27. PMEM Hendriks MMH Pennekeet TM van Gulik Peritoneal sclerosis in chronic peritoneal dialysis patients: Analysis of clinical presentation, risk factors, and peritoneal transport kinetics Perit Dial Int 17 1997 136143
28. WA Border NA Noble TGF-β in kidney fibrosis: A target for gene therapy Kidney Int 51 1997 1388 1396
29. T Oikawa M Freeman W Lo Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition Kidney Int 51 1997 164 172
30. J Witowski JD Williams N Topley D-Glucose induces transforming growth factor-β1 (TGF-β1) mRNA expression and secretion in human peritoneal mesothelial cells: Effect of hyperosmolarity Perit Dial Int 17 1997 S10 abstr; suppl 1
31. R Selgas A Lϒpez-Rivas B Miranda Characterization of the mitogenic-induced capacity of peritoneal effluent on human and mice fibroblasts in culture Nephrol Dial Transplant 6 1991 44 50
32. MJ Beavis JD Williams J Hoppe Human peritoneal fibroblast proliferation in 3-dimensional culture: Modulation by cytokines, growth factors and peritoneal dialysis effluent Kidney Int 51 1997 205 215
33. S Molina R Selgas F Vara Presence of different mitogenic activities in the nocturnal peritoneal effluent of patients treated with CAPD Adv Perit Dial 9 1993 190 194
34. C Chaimovitz Peritoneal dialysis Kidney Int 45 1994 12261240
35. GA Coles Towards a more physiologic solution for peritoneal dialysis Semin Dial 8 1995 333 335
36. R Selgas M Fernϡndez de Castro MA Bajo Transformed mesothelial cells in patients on CAPD for medium- to long term periods Perit Dial Int 15 1995 305311
37. M Nakayama Y Kawaguchi K Yamada Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD Kidney Int 51 1997 182 186
38. M Nakayama M Numata T Hasegawa Suppression of advanced glycosylation end-product formation by intermittent exposure to glucose free solution Perit Dial Int 17 1997 S98 abstr; suppl 1
39. C Higuchi T Sanaka T Sato The effect of glucose on the proliferation of peritoneal fibroblasts Adv Perit Dial 13 1997 251 256
40. R Selgas B Miranda MV Cuesta Measurement of the peritoneal platelet activity through the effluent R-thromboglobulin levels in CAPD patients Adv Perit Dial 6 1990 26 30
41. KL Donovan S Pacholok JL Humes Intraperitoneal free elastase in CAPD peritonitis Kidney Int 44 1993 87 90
42. A Breborowicz J Witowski K Wieczorowska Toxicity of free radicals to mesothelial cells and peritoneal membrane Nephron 65 1993 62 66
43. A Breborowicz DG Oreopoulos Evidence for the presence of chronic inflammation during peritoneal dialysis: Therapeutic implications Perit Dial Int 17 1997 S37 S41 suppl 2
44. A Brauner B Hylander B Wretlind Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis Am J Kidney Dis 22 1993 430 435
45. J Dobbie MK Mukundrai Role of imbalance of intracavity fibrin formation and removal in the pathogenesis of peritoneal lesions in CAPD Perit Dial Int 17 1997 121 124
46. R Selgas MV Cuesta C Rinϒn Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) levels in plasma and peritoneal effluent in patients on CAPD Adv Perit Dial 8 1992 160 165
47. JJ Lin L Parton G Bereket Plasminogen activator inhibitor-1 and peritoneal transport in diabetic and non-diabetic peritoneal dialysis patients Clin Nephrol 44 1995 310 315
48. M Goedde T Sitter H Schiffl Coagulation- and fibrinolysis-related antigens in plasma and dialysate of CAPD patients Perit Dial Int 17 1997 162 166
49. S Bertoli M Trezzi MT Barone Progression of sclerosing encapsulating peritonitis after the end of CAPD Perit Dial Int 17 1997 S27 abstr; suppl 1
50. MM Pannekeet ALT Imholz DG Struijk The standard peritoneal permeability analysis: A tool for the assessment of peritoneal permeability characteristics in CAPD patients Kidney Int 48 1995 866 875
51. MM Ho-dac-Pannekeet JG Koopmans DG Struijk Restriction coefficients of low molecular weight solutes and macromolecules during peritoneal dialysis Adv Perit Dial 13 1997 17 22
52. R Selgas MA Bajo F Teixeira Determinaciϒn y caracterizaciϒn de la reserva funcional peritoneal en pacientes en DPCA Nefrologia 11 1991 173 177
53. K Lbpez-Revuelta J Coya R Selgas Papel diagnϒstico de la escintigrafia peritoneal en las complicaciones abdominales de la dialysis peritoneal continua ambulatoria Nefrologia 8 1988 105 111
54. R Selgas A Lbpez-Rivas F Alvaro Insulin influence (used as an additive to dialysate) on the mitogenic-induced effect of the peritoneal effluent in CAPD patients Adv Perit Dial 5 1989 161 164
55. CM Hawley DR Wall DW Johnson Recovery of gastrointestional function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis Am J Kidney Dis 26 1995 658 661
56. CP Clark D Vanderpool JT Preskitt The response of retroperitoneal fibrosis to tamoxifen Surgery 109 1991 502506
57. TM Demko JR Diamond J Groff Obstructive nephropathy as a result of retroperitoneal fibrosis: A review of its pathogenesis and associations J Am Soc Nephrol 8 1997 684 688
58. S Yokota K Kumano T Sakai Different prognoses in 7 patients with sclerosing encapsulating peritonitis (SEP) secondary to CAPD Perit Dial Int 17 1997 S41 abstr; suppl 1